“Management of hormonal therapy for the treatment of advanced hormone-dependent prostate cancer: A pharmacoeconomics assessment of the use of Degarelix – Firmagon® compared to generic triptorelin”, Acta Med Peru, vol. 28, no. 4, pp. 188–193, May 2024, Accessed: Dec. 25, 2024. [Online]. Available: https://amp.cmp.org.pe/index.php/AMP/article/view/1118